Clinical Trial Update: Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

This is a completed Phase 3 clinical trial comparing meloxicam 7.5 mg to usual-care prescription NSAIDs in patients with osteoarthritis in a managed healthcare …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)
• Usual care prescription NSAIDs

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED